Project Grant R01CA295130
Award Date
9/17/24
Completion Date
8/31/29
Dollars Obligated
$1.5M
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This $1,073,982 National Cancer Institute project grant will fund research at Washington University in University City, Missouri from January 2023 through December 2027 under the Cancer Cause and Prevention Research program (CFDA 93.393). The research aims to document unmet social needs among 300 patient-caregiver dyads where the patient has breast or gynecologic cancer. It will analyze how social needs affect biopsychosocial outcomes for patients and caregivers, including depressive symptoms,...
This federal Project Grant award of $334,233, awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, will support a comprehensive research study examining disparities in novel cancer therapies, the joint effects of cancer treatment and comorbidities, and multi-level contributors to cancer survival outcomes. The University of South Carolina, the prime awardee, will conduct innovative data linkages between the state cancer registry,...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $110,644 to Vanderbilt University to investigate aspects of the Medicare Advantage (MA) program that may pose problems for beneficiaries with serious illnesses, such as cancer. The key aims are to: 1) Describe the breadth and quality of skilled nursing facilities in MA plan networks, 2) Examine the association between oncology network breadth and MA disenrollment or plan switching for...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research program) to Emory University aims to investigate the biological and social determinants of psychosocial sequelae in advanced head and neck cancer patients receiving immunotherapy. The total award amount is $664,304.00 over the project period from August 27, 2024 to June 30, 2029. The research objectives are to: 1) understand the psychosocial burdens experienced by advanced head...
This Project Grant award of $621,732 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to evaluate a proactive identification and digital mental health intervention approach to address the unmet psychosocial needs of individuals living with likely incurable cancer. The key products or services to be delivered through this 5-year grant include: 1) Comprehensively assessing the effectiveness of a proactive identification method paired with...
This Project Grant award of $328,037 from the National Institute on Aging's Aging Research program (CFDA 93.866) will fund a longitudinal mixed methods social network analysis (MMSNA) study of the Cumberland House Reentry Program. The program aims to build social ties and enhance community engagement for older men transitioning from long-term incarceration. The study will collect dynamic sociocentric network data and qualitative data on health and interpersonal relationships to evaluate the...
The National Cancer Institute (NCI) awarded a $156,616 Project Grant under CFDA 93.393 "Cancer Cause and Prevention Research" to The Feinstein Institutes for Medical Research, a non-profit research organization. The purpose of this 2-year grant is to develop and conduct a preliminary psychometric evaluation of the Social Isolation Risk Scale (SIRS), a screening tool to identify head and neck cancer survivors at risk for social isolation. Key activities include: Developing an initial...
This Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) provides $637,596 to develop and test a video-based intervention to reduce defensive avoidance of colorectal cancer information and increase screening uptake. The research aims to reach people who would typically avoid such health information, which accounts for 20-30% of the general population. The intervention is designed to increase self-efficacy and positive affect, and will be...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $115,411.00 to evaluate dynamic changes in aging-related clinical decline among older survivors with early-stage non-small cell lung cancer. The award to Weill Medical College of Cornell University aims to identify multilevel determinants, including social determinants of health, associated with disparities in clinical decline trajectories. This longitudinal study of over 89,000 lung...
The National Cancer Institute (NCI) awarded a $578,467 Project Grant (CFDA 93.395 - Cancer Treatment Research) to Duke University to conduct a randomized controlled trial evaluating the efficacy of a telehealth-delivered psychosocial intervention called ENGAGE. The goal of the ENGAGE intervention is to decrease symptom interference (e.g., pain, fatigue, distress) and improve quality of life for patients with advanced cancer receiving care in medically underserved areas. The 5-year project will...